Blood tests after stroke could predict recovery

NCT ID NCT04663399

Recruiting now Knowledge-focused Sponsor: Fondation Ophtalmologique Adolphe de Rothschild Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how the immune system and blood clotting change in the first day after a stroke treated with a clot-removal procedure called thrombectomy. Researchers will collect blood samples from 1,200 participants to find markers that might predict how well people recover at 3 and 12 months. The goal is to better understand the body's response and improve future stroke care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors predict which stroke patients will recover better, leading to more personalized care after thrombectomy.
What could go wrong: This is an observational study, not testing a new treatment. It may not find clear links between immune markers and recovery, and results may not change current care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ISCHEMIC STROKE THROMBECTOMY

Contacts and locations

Locations

Hôpital Fondation Adolphe de Rothschild
RECRUITING

Paris, Paris, 75019, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.